Three former executives of the now-defunct Bone Care International are back in the biotech business, hoping to recreate the small Middleton pharmaceutical company’s success.
Office of Strategic Communication
Three former executives of the now-defunct Bone Care International are back in the biotech business, hoping to recreate the small Middleton pharmaceutical company’s success.